Cargando…

International external quality control assessment for the serological diagnosis of dengue infections

BACKGROUND: Dengue is endemic to the tropics and subtropics, and the most frequent of arthropod-borne viral diseases. Reliable diagnosis of dengue infection is important not only in clinical care but also in disease surveillance, the control of outbreaks, and the development of new vaccines. The dia...

Descripción completa

Detalles Bibliográficos
Autores principales: Domingo, Cristina, Alves, María Joao, de Ory, Fernando, Teichmann, Anette, Schmitz, Herbert, Müller, Rolf, Niedrig, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4392463/
https://www.ncbi.nlm.nih.gov/pubmed/25886961
http://dx.doi.org/10.1186/s12879-015-0877-0
_version_ 1782365985686159360
author Domingo, Cristina
Alves, María Joao
de Ory, Fernando
Teichmann, Anette
Schmitz, Herbert
Müller, Rolf
Niedrig, Matthias
author_facet Domingo, Cristina
Alves, María Joao
de Ory, Fernando
Teichmann, Anette
Schmitz, Herbert
Müller, Rolf
Niedrig, Matthias
author_sort Domingo, Cristina
collection PubMed
description BACKGROUND: Dengue is endemic to the tropics and subtropics, and the most frequent of arthropod-borne viral diseases. Reliable diagnosis of dengue infection is important not only in clinical care but also in disease surveillance, the control of outbreaks, and the development of new vaccines. The diagnosis of dengue infection is usually established by a variety of commercial or in-house serological protocols. The European Network for the Diagnostics of Imported Viral Diseases (ENIVD) recognized the need to survey the accuracy of dengue serological diagnostics in current use, and organized an external quality assurance (EQA) study of dengue serological practice in diagnostic laboratories. METHODS: A 15-sample panel, consisting of sera reactive against dengue plus specificity and negative controls, was sent to 48 laboratories for serological testing. The results returned by the participating laboratories were anonymized, scored, and subjected to comparison and statistical analysis. RESULTS: Ten laboratories rated all samples correctly with regard to IgM, and only three achieved the full score for IgG detection. The main handicaps in assay performance were suboptimal sensitivity of in-house IgM detection protocols by comparison with better-performing commercial ELISA tests, and the presence of IgG cross-reactivity with heterologous flaviviruses. Differences of detail in the methodology of dengue IgG antibody detection appear to underlie the disparities in accuracy observed between laboratories. CONCLUSION: This EQA study demonstrates that there is room for many laboratories to improve sensitivity in the detection of anti-dengue virus IgM antibodies, against the benchmark set by commercial antibody capture ELISA tests. The EQA shows also that cross-reactivity is a continuing issue, and IgG detection protocols must be optimized to increase their specificity. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12879-015-0877-0) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4392463
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43924632015-04-11 International external quality control assessment for the serological diagnosis of dengue infections Domingo, Cristina Alves, María Joao de Ory, Fernando Teichmann, Anette Schmitz, Herbert Müller, Rolf Niedrig, Matthias BMC Infect Dis Research Article BACKGROUND: Dengue is endemic to the tropics and subtropics, and the most frequent of arthropod-borne viral diseases. Reliable diagnosis of dengue infection is important not only in clinical care but also in disease surveillance, the control of outbreaks, and the development of new vaccines. The diagnosis of dengue infection is usually established by a variety of commercial or in-house serological protocols. The European Network for the Diagnostics of Imported Viral Diseases (ENIVD) recognized the need to survey the accuracy of dengue serological diagnostics in current use, and organized an external quality assurance (EQA) study of dengue serological practice in diagnostic laboratories. METHODS: A 15-sample panel, consisting of sera reactive against dengue plus specificity and negative controls, was sent to 48 laboratories for serological testing. The results returned by the participating laboratories were anonymized, scored, and subjected to comparison and statistical analysis. RESULTS: Ten laboratories rated all samples correctly with regard to IgM, and only three achieved the full score for IgG detection. The main handicaps in assay performance were suboptimal sensitivity of in-house IgM detection protocols by comparison with better-performing commercial ELISA tests, and the presence of IgG cross-reactivity with heterologous flaviviruses. Differences of detail in the methodology of dengue IgG antibody detection appear to underlie the disparities in accuracy observed between laboratories. CONCLUSION: This EQA study demonstrates that there is room for many laboratories to improve sensitivity in the detection of anti-dengue virus IgM antibodies, against the benchmark set by commercial antibody capture ELISA tests. The EQA shows also that cross-reactivity is a continuing issue, and IgG detection protocols must be optimized to increase their specificity. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12879-015-0877-0) contains supplementary material, which is available to authorized users. BioMed Central 2015-04-01 /pmc/articles/PMC4392463/ /pubmed/25886961 http://dx.doi.org/10.1186/s12879-015-0877-0 Text en © Domingo et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Domingo, Cristina
Alves, María Joao
de Ory, Fernando
Teichmann, Anette
Schmitz, Herbert
Müller, Rolf
Niedrig, Matthias
International external quality control assessment for the serological diagnosis of dengue infections
title International external quality control assessment for the serological diagnosis of dengue infections
title_full International external quality control assessment for the serological diagnosis of dengue infections
title_fullStr International external quality control assessment for the serological diagnosis of dengue infections
title_full_unstemmed International external quality control assessment for the serological diagnosis of dengue infections
title_short International external quality control assessment for the serological diagnosis of dengue infections
title_sort international external quality control assessment for the serological diagnosis of dengue infections
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4392463/
https://www.ncbi.nlm.nih.gov/pubmed/25886961
http://dx.doi.org/10.1186/s12879-015-0877-0
work_keys_str_mv AT domingocristina internationalexternalqualitycontrolassessmentfortheserologicaldiagnosisofdengueinfections
AT alvesmariajoao internationalexternalqualitycontrolassessmentfortheserologicaldiagnosisofdengueinfections
AT deoryfernando internationalexternalqualitycontrolassessmentfortheserologicaldiagnosisofdengueinfections
AT teichmannanette internationalexternalqualitycontrolassessmentfortheserologicaldiagnosisofdengueinfections
AT schmitzherbert internationalexternalqualitycontrolassessmentfortheserologicaldiagnosisofdengueinfections
AT mullerrolf internationalexternalqualitycontrolassessmentfortheserologicaldiagnosisofdengueinfections
AT niedrigmatthias internationalexternalqualitycontrolassessmentfortheserologicaldiagnosisofdengueinfections